Amylyx Pharmaceuticals Statistics
Total Valuation
AMLX has a market cap or net worth of $120.65 million. The enterprise value is -$247.19 million.
| Market Cap | 120.65M |
| Enterprise Value | -247.19M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AMLX has 67.78 million shares outstanding. The number of shares has increased by 19.65% in one year.
| Shares Outstanding | 67.78M |
| Shares Change (YoY) | +19.65% |
| Shares Change (QoQ) | -0.31% |
| Owned by Insiders (%) | 15.17% |
| Owned by Institutions (%) | 104.74% |
| Float | 50.92M |
Valuation Ratios
The trailing PE ratio is 2.54 and the forward PE ratio is 2.77.
| PE Ratio | 2.54 |
| Forward PE | 2.77 |
| PS Ratio | 0.32 |
| Forward PS | 1.03 |
| PB Ratio | 0.28 |
| P/FCF Ratio | 11.30 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.66 |
| Quick Ratio | 5.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.40 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.40% and return on invested capital (ROIC) is 8.04%.
| Return on Equity (ROE) | 12.40% |
| Return on Assets (ROA) | 10.70% |
| Return on Capital (ROIC) | 8.04% |
| Revenue Per Employee | $991,630 |
| Profits Per Employee | $128,310 |
| Employee Count | 384 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 0.55 |
Taxes
In the past 12 months, AMLX has paid $5.03 million in taxes.
| Income Tax | 5.03M |
| Effective Tax Rate | 9.26% |
Stock Price Statistics
The stock price has decreased by -93.98% in the last 52 weeks. The beta is -0.93, so AMLX's price volatility has been lower than the market average.
| Beta (1Y) | -0.93 |
| 52-Week Price Change | -93.98% |
| 50-Day Moving Average | 7.43 |
| 200-Day Moving Average | 15.06 |
| Relative Strength Index (RSI) | 19.70 |
| Average Volume (30 Days) | 3,278,772 |
Short Selling Information
The latest short interest is 6.51 million, so 9.61% of the outstanding shares have been sold short.
| Short Interest | 6.51M |
| Short Previous Month | 6.01M |
| Short % of Shares Out | 9.61% |
| Short % of Float | 12.79% |
| Short Ratio (days to cover) | 2.43 |
Income Statement
In the last 12 months, AMLX had revenue of $380.79 million and earned $49.27 million in profits. Earnings per share was $0.70.
| Revenue | 380.79M |
| Gross Profit | 355.35M |
| Operating Income | 38.80M |
| Pretax Income | 54.30M |
| Net Income | 49.27M |
| EBITDA | 55.39M |
| EBIT | 54.30M |
| Earnings Per Share (EPS) | $0.70 |
Balance Sheet
The company has $372.08 million in cash and $4.24 million in debt, giving a net cash position of $367.84 million or $5.43 per share.
| Cash & Cash Equivalents | 372.08M |
| Total Debt | 4.24M |
| Net Cash | 367.84M |
| Net Cash Per Share | $5.43 |
| Equity / Book Value | 433.43M |
| Book Value Per Share | 6.39 |
| Working Capital | 382.62M |
Cash Flow
In the last 12 months, operating cash flow was $11.92 million and capital expenditures -$1.24 million, giving a free cash flow of $10.68 million.
| Operating Cash Flow | 11.92M |
| Capital Expenditures | -1.24M |
| Free Cash Flow | 10.68M |
| FCF Per Share | $0.16 |
Margins
Gross margin is 93.32%, with operating and profit margins of 10.19% and 12.94%.
| Gross Margin | 93.32% |
| Operating Margin | 10.19% |
| Pretax Margin | 14.26% |
| Profit Margin | 12.94% |
| EBITDA Margin | 14.54% |
| EBIT Margin | 14.26% |
| FCF Margin | 2.80% |
Dividends & Yields
AMLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.65% |
| Shareholder Yield | -19.65% |
| Earnings Yield | 40.84% |
| FCF Yield | 8.85% |
Analyst Forecast
The average price target for AMLX is $11.00, which is 517.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.00 |
| Price Target Difference | 517.98% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 23.48% |
| EPS Growth Forecast (5Y) | 42.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMLX has an Altman Z-Score of 2.01 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 6 |